Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 Diabetes
Immuno · 01.03.2024 · 4 (1) · 91-107
DOI: 10.3390/immuno4010006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immuno, online erschienen am 01.03.2024. Verfasst von Dequina A Nicholas und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, University of California Irvine, Irvine, CA 92697, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Around 285 million people worldwide currently have type 2 diabetes and it is projected that this number will be surpassed by 2030. Therefore, it is of the utmost importance to enhance our comprehension of the disease’s development. The regulation of diet, obesity, and inflammation in type 2 diabetes is believed to play a crucial role in enhancing insulin sensitivity and reducing the risk of onset diabetes. Obesity leads to an increase in visceral adipose tissue, which is a prominent site of inflammation in type 2 diabetes. Dyslipidemia, on the other hand, plays a significant role in attracting activated immune cells such as macrophages, dendritic cells, T cells, NK cells, and B cells to visceral adipose tissue. These immune cells are a primary source of pro-inflammatory cytokines that are believed to promote insulin resistance. This review delves into the influence of elevated dietary free saturated fatty acids and examines the cellular and molecular factors associated with insulin resistance in the initiation of inflammation induced by obesity. Furthermore, it explores novel concepts related to diet-induced inflammation and its relationship with type 2 diabetes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biological Sciences, University of California Irvine, Irvine, CA 92697, USA.
- Department of Biological Sciences, School of Arts and Sciences, Oakwood University, Huntsville, AL 35896, USA.
- Center for Health Disparities and Molecular Medicine, School of Medicine, Loma Linda University, Loma Linda, CA 11085, USA.
- Division of Molecular Genetics and Microbiology, School of Medicine Alumni Hall, Loma Linda University, Rm 102, 11021 Campus Street, Loma Linda, CA 92350, USA.
- Center for Perinatal Biology, Division of Physiology, Loma Linda School of Medicine, Rm A572, 11234 Anderson Street, Loma Linda, CA 92350, USA.
ORCID-Profile: Dequina A Nicholas, Jacques C Mbongue, Marino De Leon
Förderung
- NIGMS NIH HHS
Zitieren
APA
Nicholas, D. A., Mbongue, J. C., Garcia-Pérez, D., Sorensen, D., Ferguson Bennit, H., De Leon, M., & Langridge, W. H. R. (2024). Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 Diabetes. Immuno, 4(1), 91-107. https://doi.org/10.3390/immuno4010006
Vancouver
Nicholas DA, Mbongue JC, Garcia-Pérez D, Sorensen D, Ferguson Bennit H, De Leon M, et al. Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 Diabetes. Immuno. 2024;4(1):91-107. doi:10.3390/immuno4010006
BibTeX
@article{Nicholas2024,
author = {Nicholas, Dequina A and Mbongue, Jacques C and Garcia-Pérez, Darysbel and Sorensen, Dane and Ferguson Bennit, Heather and De Leon, Marino and Langridge, William H R},
title = {Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 Diabetes},
journal = {Immuno},
year = {2024},
volume = {4},
number = {1},
pages = {91--107},
doi = {10.3390/immuno4010006}
}
EUVIMED